Comparison of the efficacy and safety of asthma treatments; fluticasone furoate/vilanterol trifenatate and fluticasone propionate. - Trial 2015-004868-11
Access comprehensive clinical trial information for 2015-004868-11 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Mean change from Baseline (BL) in daily evening (PM) peak expiratory flow (PEF) averaged over the 12-week Treatment Period
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004868-11
Non-Device Trial